CRYAB and neoplasm: Additionally, CRYAB and CD44 are highly co-expressed in aggressive GBM, synergistically regulating cytoskeletal remodeling and anti-apoptotic signaling pathways, which significantly enhances the tumor's recurrence after surgery.47